The Melanoma Hub – Home › Forums › Targeted therapy › Dosing and administration › New BRAF/MEK inhibitors coming to market › Reply To: New BRAF/MEK inhibitors coming to market
March 24, 2018 at 12:40 pm
#4771
Has anyone heard an update on when the FDA will be approving these medications? We have a few patients whose Pyrexia on danrafenib and tramatenib is really signicant and even with various interventions we are not able to keep them consistently on drugs.